Michelle Robertson

2020 - Editas Medicine

In 2020, Michelle Robertson earned a total compensation of $3.6M as Chief Financial Officer at Editas Medicine.

Compensation breakdown

Bonus$140,000
Non-Equity Incentive Plan$112,880
Option Awards$2,374,080
Salary$387,692
Stock Awards$613,000
Other$6,690
Total$3,634,342

Robertson received $2.4M in option awards, accounting for 65% of the total pay in 2020.

Robertson also received $140K in bonus, $112.9K in non-equity incentive plan, $387.7K in salary, $613K in stock awards and $6.7K in other compensation.

Rankings

In 2020, Michelle Robertson's compensation ranked 3,191st out of 13,090 executives tracked by ExecPay. In other words, Robertson earned more than 75.6% of executives.

ClassificationRankingPercentile
All
3,191
out of 13,090
76th
Division
Manufacturing
1,245
out of 5,621
78th
Major group
Chemicals And Allied Products
471
out of 2,254
79th
Industry group
Drugs
408
out of 1,954
79th
Industry
Biological Products, Except Diagnostic Substances
102
out of 411
75th

Pay ratio

Michelle Robertson's Pay$3,634,342
Median Employee's Pay$162,706
Pay Ratio

22

to 1

In 2020, the annual total compensation of Michelle Robertson was $3,634,342.

The annual total compensation of the median employee at Editas Medicine was $162,706.

The ratio of Michelle Robertson's pay to the pay of median employee was therefore 22 to one.

Source: SEC filing on April 20, 2021.

Robertson's colleagues

We found five more compensation records of executives who worked with Michelle Robertson at Editas Medicine in 2020.

2020

Lisa Michaels

Editas Medicine

Chief Medical Officer

2020

Cynthia Collins

Editas Medicine

Chief Executive Officer

2020

Charles Albright

Editas Medicine

Chief Scientific Officer

2020

Judith Abrams

Editas Medicine

Chief Medical Officer

2020

Eric Ek

Editas Medicine

Chief Financial Officer

News

In-depth

You may also like